You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
NEW YORK — SphingoTec said on Tuesday that it has signed commercialization agreements with Sysmex and its subsidiary Hitado for its Nexus IB10 point-of-care immunoassay platform in Switzerland and Germany, respectively.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?Login Now.
Don't have a 360Dx or GenomeWeb account?Register for Free.